Image
Pagliuca-photo-web.jpg
Research Title
Impact of Eltrombopag treatment in combination with immunosuppression on the immune derangement of aplastic anemia: A translational research from RACE trial
Original Research Center
University Federico II of Naples, Naples, Italy, and Saint Louis Hospital, Paris, France
Pubmed Author Name
Pagliuca S

RACE is a phase III randomized study initiated in 2015 whose aim was to evaluate whether the standard first-line therapy for severe aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most… (anti-thymoglobuline and cyclosporine: Cyclosporine is used along with antithymocyte globulin (ATG), another immunosuppressant, for treating aplastic anemia and some other forms of bone marrow failure. ) could be improved by the addition of eltrombopag: What are the possible side effects of eltrombopag (Promacta)? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using eltrombopag and call your doctor at once if you have: … , a small molecule previously showing a promising effect in stimulating hematopoiesis: (hi-mat-uh-poy-EE-suss) The process of making blood cells in the bone marrow. .  

The purpose of the present translational research was to understand how the aberrant immune response characterizing aplastic anemia could be modified by the introduction of eltrombopag.  

RACE trial has recently concluded and results are under publication.  

Institution
Cleveland Clinic Taussig Cancer Institute

Dr. Pagliuca is working in Jaroslaw Maciejewski's lab at Cleveland Clinic and her research is focused on the immunogenetics of immune-mediated bone marrow failure: A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life) or can be… disorders.  

She is dissecting the role of human leukocyte antigen: (LEW-kuh-site ANT-i-jun) One of a group of proteins found on the surface of white blood cells and other cells. These antigens differ from person to person. A human leukocyte antigen test is done before a stem cell transplant to closely match a donor and a recipient. Also called HLA. (HLA) diversity in predisposing to autoimmunity in aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most… .  Moreover, she studies how molecular changes affecting those molecules (critical elements of the immune response) may impact hematopoietic recovery and clonal evolution.  

Also, the place of eltrombopag: What are the possible side effects of eltrombopag (Promacta)? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using eltrombopag and call your doctor at once if you have: … in stimulating hematopoiesis: (hi-mat-uh-poy-EE-suss) The process of making blood cells in the bone marrow. and potentially affecting immunity has been granularly investigated in another independent research from Cleveland Clinic. These results are currently under publication.

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.